MetLife Securities’ Largest Q3 Healthcare Stock Investments: ABT, JNJ, PFE, NVS

Wall St. Watchdog reveals information regarding MetLife Securities’ top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 127 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $10.153 million.

  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, MetLife Securities reported holding 21,367 shares with a market value of $1,124,332. This comprised 0.43% of the total portfolio. On 09/30/2011, MetLife Securities reported holding 41,901 shares with a market value of $2,142,817. This comprised 0.87% of the total portfolio. The net change in shares for this position over the two quarters is 20,534. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, MetLife Securities reported holding 23,987 shares with a market value of $1,595,615. This comprised 0.62% of the total portfolio. On 09/30/2011, MetLife Securities reported holding 25,983 shares with a market value of $1,654,857. This comprised 0.67% of the total portfolio. The net change in shares for this position over the two quarters is 1,996. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, MetLife Securities reported holding 11,950 shares with a market value of $421,716. This comprised 0.16% of the total portfolio. On 09/30/2011, MetLife Securities reported holding 18,602 shares with a market value of $608,285. This comprised 0.25% of the total portfolio. The net change in shares for this position over the two quarters is 6,652. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, MetLife Securities reported holding 29,776 shares with a market value of $613,386. This comprised 0.24% of the total portfolio. On 09/30/2011, MetLife Securities reported holding 34,261 shares with a market value of $605,734. This comprised 0.25% of the total portfolio. The net change in shares for this position over the two quarters is 4,485. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Novartis Ag (NYSE:NVS): On 06/30/2011, MetLife Securities reported holding 6,074 shares with a market value of $371,182. This comprised 0.14% of the total portfolio. On 09/30/2011, MetLife Securities reported holding 10,688 shares with a market value of $596,070. This comprised 0.24% of the total portfolio. The net change in shares for this position over the two quarters is 4,614. About Company: Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases; oncology, neuroscience, transplantation, dermatology, gastrointestinal and urinary conditions, and arthritis; vaccines and diagnostics; vision, and animal health products.
  • Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): On 06/30/2011, MetLife Securities reported holding 5,711 shares with a market value of $275,384. This comprised 0.11% of the total portfolio. On 09/30/2011, MetLife Securities reported holding 13,026 shares with a market value of $484,828. This comprised 0.2% of the total portfolio. The net change in shares for this position over the two quarters is 7,315. About Company: Teva Pharmaceutical Industries Ltd. develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis. Teva develops novel drugs for diseases of the central nervous system.
  • Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011, MetLife Securities reported holding 14,953 shares with a market value of $433,039. This comprised 0.17% of the total portfolio. On 09/30/2011, MetLife Securities reported holding 13,216 shares with a market value of $414,718. This comprised 0.17% of the total portfolio. The net change in shares for this position over the two quarters is -1,737. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Healthspring Inc. (NYSE:HS): On 06/30/2011, MetLife Securities reported holding 9,580 shares with a market value of $441,734. This comprised 0.17% of the total portfolio. On 09/30/2011, MetLife Securities reported holding 8,985 shares with a market value of $327,593. This comprised 0.13% of the total portfolio. The net change in shares for this position over the two quarters is -595. About Company: Healthspring, Inc. is a health maintenance organization. The Company serves Medicare recipients with a comprehensive network of hospitals and physicians.
  • Celgene Corporation (NASDAQ:CELG): On 06/30/2011, MetLife Securities reported holding 5,212 shares with a market value of $314,388. This comprised 0.12% of the total portfolio. On 09/30/2011, MetLife Securities reported holding 5,036 shares with a market value of $311,779. This comprised 0.13% of the total portfolio. The net change in shares for this position over the two quarters is -176. About Company: Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, MetLife Securities reported holding 3,650 shares with a market value of $188,267. This comprised 0.07% of the total portfolio. On 09/30/2011, MetLife Securities reported holding 5,030 shares with a market value of $231,984. This comprised 0.09% of the total portfolio. The net change in shares for this position over the two quarters is 1,380. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.

(Note: Data regarding MetLife Securities’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet